Pub. Date : 1997 May 1
PMID : 9129042
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. | Arsenic Trioxide | PML nuclear body scaffold | Homo sapiens |
| 2 | Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. | Arsenic Trioxide | PML nuclear body scaffold | Homo sapiens |
| 3 | The therapeutic effect of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) was evaluated among 15 APL patients at relapse after all-trans retinoic acid (ATRA) induced and chemotherapy maintained complete remission (CR). | Arsenic Trioxide | PML nuclear body scaffold | Homo sapiens |
| 4 | The therapeutic effect of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) was evaluated among 15 APL patients at relapse after all-trans retinoic acid (ATRA) induced and chemotherapy maintained complete remission (CR). | Arsenic Trioxide | PML nuclear body scaffold | Homo sapiens |